-44%

est. 2Y upside i

HealthcareSeries B

Throne is building the first wearable for your toilet that tracks gut health and hydration with every flush. Our mission is to improve health and, one day, save lives by making gut health as easy to track as sleep. Today, WHOOP for your poop – tomorrow, the smoke detector for colon cancer.

Rank

#826

Sector

HealthTech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Throne offers a moderate upside opportunity for a job seeker, driven by its early mover advantage in the rapidly expanding smart toilet health monitoring market, projected to grow at over 50% CAGR.

Last updated: March 10, 2026

Bull (35%)+250%

Throne successfully expands its product line to include advanced diagnostic capabilities, securing key partnerships with health systems and insurers. This drives rapid adoption in a market growing at over 50% CAGR, pushing annual recurring revenue (ARR) to $75M by 2028 and justifying a $330M+ valuation at a premium multiple, well above the current $95M.

Base (35%)+75%

Throne continues to grow steadily, capturing a niche in the wellness market with its smart toilet device. It achieves $30M ARR by 2028, maintaining its gross margin and fending off initial competitive threats. This growth supports a $165M valuation, representing a solid return but facing ongoing competition from emerging players.

Bear (30%)-60%

Incumbent health tech companies like Withings launch more comprehensive and aggressively priced competing smart toilet solutions, or a major tech giant enters the market, leading to commoditization. Throne struggles to differentiate, resulting in slower-than-expected adoption and a down round to a $35M valuation, significantly eroding common stock value due to the existing $19M in liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

20%

Investors hold $19M in liquidation preferences, meaning common stock holders would see returns only after this amount is paid out to preferred shareholders.

Dilution Risk

moderate

As a Series B company, Throne will likely require 1-2 more funding rounds before a potential IPO or acquisition, implying further dilution for existing equity holders.

Secondary Liquidity

none

No active secondary market or tender offers are indicated for a company at this funding stage and size.

Questions to Ask at the Interview

Strategic questions based on Throne's data — designed to show you've done your homework.

  • 1

    “Given the projected 50.7% CAGR for the health monitoring smart toilet market, how is Throne planning to accelerate consumer adoption beyond early adopters, and what specific strategies are in place to differentiate from competitors like Withings?”

  • 2

    “With the 'general wellness product' positioning, how does Throne plan to navigate the line between consumer wellness and potential future clinical applications, especially considering the regulatory landscape and the need for data privacy?”

  • 3

    “Considering the Series B funding and the current $95M valuation with a $19M liquidation preference, what is the company's strategy for achieving a liquidity event within the next 2-3 years, and how will future funding rounds impact employee equity?”

Community

Valuation Sentiment

Our model estimates -44% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.